Immuno-Oncological Center IOZK Cologne

9.90

Cologne, Germany

User Score	Total Reviews	Rating	Price Range	Media Files	Certificates	Founded In	Departments	Ownership	Clinical trials	Age Group	Clinic Type	Type of Care	Size	Online Consultations
99%	16	9.9/10	$$$$	8	2	1985	1 medical unit	Private hospital	Conduct clinical trials	Kids, Adults	Specialized	Inpatient, Outpatient	Small	Yes

Overview

Size

Small

Clinic type

Specialized

Type of care

Inpatient, Outpatient

Age group

Kids, Adults

4.2 on Google

The data collected based on 16 patient reviews on Google

Certificates

Features & Facts

Vaccination against cancer

A personalized IO-VAC vaccine is created for every patient by combining their blood cells with an oncolytic virus grown in a lab. It helps the patient's immune system recognize and attack the protective barriers of breast, skin, and lung cancer.

Specialized research

The IOZK laboratory is the only one in Europe that has received a license to produce a personalized cancer vaccine from dendritic cells using an oncolytic virus and a patient's tumor material.

Pioneers in personalized medicine

This center offers personalized immunotherapy to over 350 patients annually worldwide. A global study on glioblastoma found that patients who received the dendritic cell vaccine had double the survival rate of those who underwent standard therapy.

The best oncologists in the world

Dr. Wilfried Stucker, the clinic's founder, specializes in personalized cancer immunotherapy. The IOZK treatment is a new approach to combat cancer, and the clinic's receipt of the German Medical Award in 2020 is evidence of its effectiveness.

New, unique, approved

It is the only clinic offering antitumor vaccination in combination with oncolytic virotherapy and hyperthermia. They have vast experience and have effectively treated over 2,000 patients over the past few years.

About the clinic

Immuno-Oncological Center IOZK Cologne specializes in individual cancer therapy with specific immune system activation. A team of leading physicians and experienced scientists work together in an interdisciplinary manner. In the clinic, the results of fundamental immunological research are directly applied to the treatment of cancer patients. As a result, IOZK offers important therapeutic options that complement and enhance traditional tumor treatments. IOZK is a treatment medical facility with a laboratory in Cologne, Germany. The extensive treatment center comprises examination and consultation rooms, conference rooms, offices, and state-of-the-art laboratories of the highest standard. The doctors and scientists of the clinic have been working on the immune system's role in developing cancer and chronic infectious diseases since 1985. A team at the medical center has developed the first autologous cancer vaccine in Europe, which has been approved following regulatory guidelines. The IO-VAC® cancer vaccine activates the patient's immune system and allows it to start fighting cancer cells. The vaccine uses the patient's dendritic cells, tumor antigens, and an oncolytic virus. IOZK individual immunotherapy is considered a pioneering solution in the fight against cancer. The medical center received the German Medical Prize 2020 for the discovery. Current standard therapies attempt to fight the tumor but do not consider the potential of the body's defense mechanisms against tumor growth. The clinic's treatment is based on a combination of specific immunotherapy adapted to the patient's individual immunological and oncological needs. The specialists of the medical center have exceptional experience in the field of internal medicine, oncology, pediatric hemato-oncology, and immunology. The range of therapeutic services of the clinic includes immunotherapy, antitumor vaccination, antibody therapy, hyperthermia, and supportive measures to strengthen the immune system and patients. With the help of complex individual therapy, doctors can offer patients gentle treatment and the best quality of life.

Primary focus

Departments & Doctors

Oncology, immunotherapy, cancer vaccines

Dr. med. Wilfried Stucker

oncology, personalized cancer vaccine, immunotherapy

Gallery

Immuno-Oncological Therapy. An alternative cancer therapy. - IOZK

Trailer: Immunological cancer therapy at the Immuno-Oncological Center IOZK in Cologne.

Extra services

Visa Support

Telemedicine

Accessibility Features

Location

Hohenstaufenring 30-32, 50674 Köln, Germany

FAQ

What types of tumors can be treated in Immuno-Oncological Center Cologne?

Oncologists use immunotherapy to treat malignant skin cancer, breast cancer, bile duct carcinoma, and brain tumors. Numerous studies have shown that therapy is effective and relatively well tolerated in various tumor types. In addition, the technique allows for an extension of the life span.

What are the patient benefits of immunotherapy compared to classical oncology?

Despite the latest surgery, chemotherapy, and radiation technologies, healthy body cells are still damaged. On the contrary, immunotherapy has a specific effect: only malignant cells are killed, with practically no side effects. Therefore, immuno-oncological treatment is the most gentle method.

When is the best time to administer IOZK immunotherapy?

IOZK therapy can be carried out at any time during tumor growth. However, recent data show that immunotherapy in the early stages of the disease produces the best long-term results. Cancer vaccination and immunotherapy can also be combined with any conventional treatment.